Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 102.15M P/E - EPS this Y -5.20% Ern Qtrly Grth -
Income -36.9M Forward P/E -2.45 EPS next Y 26.20% 50D Avg Chg -10.00%
Sales 10k PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 2.02 EPS next 5Y - 52W High Chg -62.00%
Recommedations 1.70 Quick Ratio 6.14 Shares Outstanding 64.45M 52W Low Chg 189.00%
Insider Own 3.08% ROA -50.55% Shares Float 40.31M Beta 2.19
Inst Own 53.41% ROE -90.72% Shares Shorted/Prior 3.01M/1.49M Price 1.59
Gross Margin 100.00% Profit Margin - Avg. Volume 235,490 Target Price 7.00
Oper. Margin -95,908.34% Earnings Date May 9 Volume 196,247 Change -3.64%
About GlycoMimetics, Inc.

GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.

GlycoMimetics, Inc. News
04/28/24 We're Keeping An Eye On GlycoMimetics' (NASDAQ:GLYC) Cash Burn Rate
04/25/24 GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
07:41 AM Loss-Making GlycoMimetics, Inc. (NASDAQ:GLYC) Expected To Breakeven In The Medium-Term
03/28/24 GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript
03/28/24 Q4 2023 GlycoMimetics Inc Earnings Call
03/27/24 GlycoMimetics Inc (GLYC) Posts Quarterly Loss, Aligns with Analyst Projections
03/27/24 GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
03/21/24 Should You Buy GlycoMimetics (GLYC) Ahead of Earnings?
03/13/24 GlycoMimetics to Report Fourth Quarter and 2023 Full Year Financial Results on March 27, 2024
03/04/24 Positive Signs As Multiple Insiders Buy GlycoMimetics Stock
02/26/24 GlycoMimetics to Participate in Upcoming Cowen 44th Annual Health Care Conference
02/12/24 GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
01/04/24 GlycoMimetics Announces Positive Initial Safety and Pharmacokinetic Results from Phase 1a Healthy Volunteer Study of GMI-1687
01/03/24 Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
12/17/23 Retail investors in GlycoMimetics, Inc. (NASDAQ:GLYC) are its biggest bettors, and their bets paid off as stock gained 23% last week
12/10/23 GlycoMimetics Announces Independent Presentations on Uproleselan at American Society of Hematology Annual Meeting including New Clinical Data in Treated Secondary Acute Myeloid Leukemia
11/20/23 Is GlycoMimetics (NASDAQ:GLYC) In A Good Position To Invest In Growth?
11/09/23 GlycoMimetics to Participate in Upcoming Jefferies London Healthcare Conference
11/05/23 GlycoMimetics, Inc. (NASDAQ:GLYC) Q3 2023 Earnings Call Transcript
11/04/23 Q3 2023 GlycoMimetics Inc Earnings Call
GLYC Chatroom

User Image Yoshino2009 Posted - 5 minutes ago

$GLYC You have been warned. It’s leaked. “Exploring options” with data not meeting primary and secondary endpoints.

User Image thisisbob Posted - 17 minutes ago

$GLYC Nice Pump N Dump

User Image Haywood_Yablome Posted - 1 hour ago

$GLYC Not a great comeback honestly but in any case, why do people take it so personally? Like I just called the guy’s kids ugly or something. Which Incidentally I’m guessing that they probably are but that doesn’t mean you gotta stop loving ‘em right? So yeah, it’s kinda like that I guess. I can hold the stock and still make fun of it for being ugly, right? And geesh man, he even says “no offense!” But I do feel bad now about saying earlier that his kids are probably really really ugly. 😔 I shouldn’t have said that but unfortunately he blocked me and so if someone could relay my apologies on to him that’d be great. Thx.

User Image Disturbed69 Posted - 1 hour ago

$GLYC are the pussy people selling again

User Image Haywood_Yablome Posted - 3 hours ago

$GLYC

User Image Stockpicker9 Posted - 4 hours ago

$GLYC nothing more to say 🤟 shortys what are your points.... it s a no brainer⭐️

User Image ElectricJ Posted - 5 hours ago

$GLYC

User Image calucci59 Posted - 5 hours ago

$GLYC What is an effective treatment for Oral Mucositis alone worth?? Upro = 2% vs 40%+ https://jeccr.biomedcentral.com/articles/10.1186/s13046-020-01715-7#:~:text=About%2040%25%20of%20the%20patients,with%20both%20chemo%2D%20and%20radiotherapy.

User Image Stockpicker9 Posted - 5 hours ago

$GLYC people do realize that they already are good... they had the results already last year but fda wanted mor months...🤪🤪 no brainer - and if u dont believe read the news last year

User Image nycmax2002 Posted - 5 hours ago

$GLYC LOL 20% up from yesterday....please go to 3 and I will sell half and let rest ride into data.

User Image pmcd777 Posted - 5 hours ago

$GLYC all posts on yoshino's profile are bear posts, and with no substantive argument. Just an emotional stock basher. Easy block. Buh-bye.

User Image getsometoday Posted - 6 hours ago

$GLYC some people for whatever reason are not ever bullish on any stock. Hmmmmm🤥

User Image ZonataTwits Posted - 6 hours ago

$GLYC Next - 1 follower Yoshino2009 fail to create fear to cover and go bankrupt.

User Image Yoshino2009 Posted - 6 hours ago

$GLYC Next - Did not meet endpoints “exploring options” coming. Data was leaked then the drop. Once announced back to $.50. IMHO

User Image Will2ride1 Posted - 13 hours ago

$GLYC go time 📈

User Image jehruun Posted - 04/30/24

$GLYC OH SHIT ITS DAT BOI WHADDU

User Image Disturbed69 Posted - 04/30/24

$GLYC and down she goes at at least 10% after hours

User Image AnalRetort Posted - 04/30/24

@Scooter0732 @whey81 I added $glyc this morning

User Image Achouffe Posted - 04/30/24

$GLYC This feels completely orchestrated. Q is by who?

User Image lyonsa14 Posted - 04/30/24

$GLYC Investors seem to be very confused with this stock. We shall soon see what the truth is. Don’t understand why it was cut in half unless the data is bad but then why is it rallying? If the data is truly bad, then the share price should actually drop below $1. May be just too many gamblers out there who don’t understand what they’re buying. Or, simply they are assuming it will fail since so many phase 3 AML trials fail with an OS endpoint.

User Image lqqkerinsiderDOTcom Posted - 04/30/24

$GLYC I guess the drug works after all.

User Image lyonsa14 Posted - 04/30/24

$GLYC 100% agree with your comment. Not sure why investors are confused about this concept.

User Image Biopharma15 Posted - 04/30/24

$GLYC Ignore anyone spreading fear about dilution. There was always going to be an offering if data hits because they need cash to bring upro to market. But come on they will not need to issue all 50 million shares to raise enough money when the SP jumps after positive data, that’s idiotic. And if the trial fails, this is cratering below $0.5 and company is toast anyway.

User Image Scooter0732 Posted - 04/30/24

$GLYC that drop was a bit much

User Image ModeWolfOfMainStrtTwits Posted - 04/30/24

$GLYC glad my baby glyc still loves red

User Image Disturbed69 Posted - 04/30/24

$GLYC I feel like people are going to take profits and a little. I’m bullish on this but when they add 50 million more shows, it’s gonna drop the price.

User Image Yoshino2009 Posted - 04/30/24

$GLYC When will they start offerings? The just voted the add 50% increase to authorized shares from 100 million to 150 million. Please don’t tell me they are just adding it. It doesn’t mean they will use it. They will.

User Image theophil Posted - 04/30/24

$GLYC added 1500

User Image nycmax2002 Posted - 04/30/24

$GLYC green today? I was getting worried we would test 1.2. Locked loading 5000 shares with 1.7 average.

User Image pmcd777 Posted - 04/30/24

$GLYC "someone knows sumthin'"

Analyst Ratings
HC Wainwright & Co. Buy Mar 27, 24
Capital One Overweight Dec 22, 23
HC Wainwright & Co. Buy Aug 3, 23
HC Wainwright & Co. Buy Jun 15, 23
HC Wainwright & Co. Buy May 4, 23
HC Wainwright & Co. Buy Mar 30, 23
HC Wainwright & Co. Buy Feb 16, 23
HC Wainwright & Co. Buy Aug 4, 22
Jefferies Buy Nov 12, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
JUNIUS DANIEL M Director Director May 10 Buy 1.56 30,000 46,800 93,250 05/11/23
Invus Public Equities, L.P. 10% Owner 10% Owner Feb 21 Buy 1.8 400,000 720,000 8,489,064 02/23/23
Invus Public Equities, L.P. 10% Owner 10% Owner Feb 15 Buy 1.85 1,515,266 2,803,242 8,089,064 02/17/23
Invus Public Equities, L.P. 10% Owner 10% Owner Feb 09 Buy 3.2419 11,451 37,123 6,573,798 02/13/23
SANDELL SCOTT D 10% Owner 10% Owner Jan 25 Sell 3.19 3,652,016 11,649,931 2,237,196 01/27/23
SANDELL SCOTT D 10% Owner 10% Owner Jan 05 Sell 2.76 71,362 196,959 3,881,933 01/06/23
Rock Edwin Chief Medical Office.. Chief Medical Officer Dec 22 Buy 2.25 110,000 247,500 310,000 12/27/22
Magnani John L. SVP of Research, CSO SVP of Research, CSO Mar 09 Sell 1.09 3,227 3,517 321,033 03/10/22
Girard Armand SVP, Chief Business.. SVP, Chief Business Officer Mar 09 Sell 1.09 2,339 2,550 22,661 03/10/22
Hahn Brian M. SVP Finance, CFO SVP Finance, CFO Mar 09 Sell 1.09 2,917 3,180 36,843 03/10/22